Need for Improved CVD Prevention in Patients With RA

August 01, 2020


Patients with rheumatoid arthritis (RA) have a higher risk of cardiovascular disease (CVD), because inflammation plays a pivotal role in the development of CVD. However, there is a need for greater improvement of CVD risk prevention.

ACR Issues Advice on Reopening Clinics During the COVID-19 Pandemic

July 30, 2020


During the coronavirus disease 2019 (COVID-19) pandemic, clinics have closed to varying degrees. As clinics look to reopen or welcome back patients after a COVID-19 infection, the American College of Rheumatology (ACR) has released advice on strategies for reopening practices as the pandemic continues.

Greater Disease Burden in Patients With Skin and Joint Symptoms for Psoriatic Arthritis

July 30, 2020


Patients who have both skin and joint symptoms with psoriatic arthritis have greater disease burden and worse quality of life compared with patients who have joint-only involvement.

Tocilizumab Caused Serious AEs in a Quarter of Children With Rheumatic Inflammatory Diseases

July 25, 2020


In children with inflammatory rheumatic diseases, tocilizumab can cause serious adverse events (AEs), with children who were younger at disease onset and at time of tocilizumab initiation especially affected.

Secukinumab Dose Escalation, Retention Rate, and Safety in Real-World Settings

July 23, 2020


In 2 studies of secukinumab use in real-world settings, researchers identified the usefulness of dose escalation in patients with psoriatic arthritis (PsA), as well as the safety, retention rate, and factors associated with drug survival among patients with PsA and ankylosing spondyloarthritis.

Indirect Nonhealth Care Costs Drive Total Costs in Psoriatic Arthritis and Psoriasis

July 18, 2020


Psoriatic arthritis and psoriasis have high economic burdens and the total annual costs were similar between the 2 diseases, but the combination of both yielded the highest costs, according to an abstract published at the European League Against Rheumatism annual meeting.

Identifying Factors of Delayed Diagnosis in Axial Spondyloarthritis

July 16, 2020


Although early diagnosis of axial spondyloarthritis is crucial for patients to receive timely access to care and effective treatment, these patients experience a diagnostic delay of more than 7 years, on average.

Upadacitinib Proves to Be More Effective Than Methotrexate in Patients With RA

July 11, 2020


Clinical trial result revealed that upadacitinib may be more effective in treating patients with rheumatoid arthritis than the gold standard of care, methotrexate.

Factors Affecting Efficacy of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis

July 09, 2020


Treatment options for psoriatic arthritis and axial spondyloarthritis are increasing, and with studies already identifying response predictors for tumor necrosis factor inhibitors, there is a need to predict response to the interleukin-17A inhibitor secukinumab.

ACR Position Statement Supports Use of Telemedicine After COVID-19 Crisis

July 03, 2020


The coronavirus disease 2019 (COVID-19) public health emergency has led to an increased use of telemedicine services as CMS instituted reimbursement parity with in-person services. In a new position statement, the American College of Rheumatology has stated support for continuing to use telemedicine once the COVID-19 emergency passes.